REGENEREX PHARMA, INC. Accretion Expense
REGENEREX PHARMA, INC. reported Accretion Expense of $2.00 thousand for the 53-month period ending 2014-11-30, per its 10-K filed 2015-03-03.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AccretionExpense · last filed 2015-03-03
- REGENEREX PHARMA, INC. accretion expense for fiscal 2013 was $2.00K.
| Period end | Accretion Expense 12 month | Accretion Expense 47 month | Accretion Expense 50 month | Accretion Expense 53 month |
|---|---|---|---|---|
| 2014-11-30 | $2.00K 10-K · filed 2015-03-03 | |||
| 2014-08-31 | $2.00K 10-Q · filed 2014-10-20 | |||
| 2014-05-31 | $2.00K 10-Q · filed 2014-07-23 | |||
| 2013-11-30 | $2.00K 10-K · filed 2015-03-03 |